All stock lists
CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
Healthcare · Biotechnology
7.99+0.14 (+1.72%)
Insider Score
––Not scored
CRMD Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CRMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 99.31 M | 127.43 M | 128.62 M | 104.28 M | 39.74 M |
| Revenue Growth (YoY) | 149.92 % | — | — | — | — |
| Cost of Revenue | 24.80 M | 22.30 M | 21.31 M | 11.19 M | 1.86 M |
| Gross Profit | 74.50 M | 105.12 M | 107.31 M | 93.08 M | 37.87 M |
| SG&A Expense | 27.53 M | 34.25 M | 39.58 M | 36.64 M | 15.89 M |
| R&D Expense | 6.68 M | 7.21 M | 8.60 M | 5.10 M | 2.44 M |
| Operating Expenses | 31.59 M | 41.46 M | 48.18 M | 41.73 M | 18.33 M |
| Operating Income | 42.91 M | 63.66 M | 59.13 M | 51.35 M | 19.54 M |
| Pretax Income | 38.73 M | 55.65 M | 56.45 M | 52.58 M | 20.35 M |
| Tax Provision | 12.74 M | 17.04 M | 42.43 M | -55.99 M | 522.00 K |
| Net Income | 25.99 M | 38.60 M | 14.02 M | 108.56 M | 19.83 M |
| EPS (Basic) | 0.33 | 0.48 | 0.18 | 1.42 | 0.29 |
| EPS (Diluted) | 0.29 | 0.43 | 0.16 | 1.26 | 0.28 |
| Shares Outstanding | 78.44 M | 79.51 M | 78.84 M | 75.93 M | 67.93 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.